| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.9 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.024 | 0.9 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.0091 | 0.9 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | -0.023 | 0.9 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.0071 | 0.9 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.0087 | 0.9 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |